75 related articles for article (PubMed ID: 2541363)
1. Changes in blood-brain barrier function modify the neuroendocrine response to circulating substances.
Jezová D; Johansson BB; Oprsalová Z; Vigas M
Neuroendocrinology; 1989 Apr; 49(4):428-33. PubMed ID: 2541363
[TBL] [Abstract][Full Text] [Related]
2. Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrier.
Jezová D; Bartanusz V; Westergren I; Johansson BB; Rivier J; Vale W; Rivier C
Endocrinology; 1992 Feb; 130(2):1024-9. PubMed ID: 1310274
[TBL] [Abstract][Full Text] [Related]
3. Divergent prolactin and pituitary-adrenal activity in rats selectively bred for different dopamine responsiveness.
Rots NY; Cools AR; Oitzl MS; de Jong J; Sutanto W; de Kloet ER
Endocrinology; 1996 May; 137(5):1678-86. PubMed ID: 8612501
[TBL] [Abstract][Full Text] [Related]
4. Apomorphine-induced limb flicks in cats: the role of dopamine receptors located outside the blood-brain barrier.
Stewart BR; Broekkamp CL
Psychopharmacology (Berl); 1988; 95(2):268-70. PubMed ID: 3137609
[TBL] [Abstract][Full Text] [Related]
5. Neural transplants disrupt the blood-brain barrier and allow peripherally acting drugs to exert a centrally mediated behavioral effect.
Sandberg PR; Nash DR; Calderon SF; Giordano M; Shipley MT; Norman AB
Exp Neurol; 1988 Oct; 102(1):149-52. PubMed ID: 3181349
[TBL] [Abstract][Full Text] [Related]
6. Endothelial negative surface charge areas and blood-brain barrier function.
Hardebo JE; Kåhrström J
Acta Physiol Scand; 1985 Nov; 125(3):495-9. PubMed ID: 4083048
[TBL] [Abstract][Full Text] [Related]
7. Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury.
Pan W; Banks WA; Kastin AJ
Exp Neurol; 1997 Aug; 146(2):367-73. PubMed ID: 9270046
[TBL] [Abstract][Full Text] [Related]
8. Albumin content in brain and CSF after intracarotid infusion of protamine sulfate: a longitudinal study.
Westergren I; Johansson BB
Exp Neurol; 1990 Feb; 107(2):192-6. PubMed ID: 2303128
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of amino acids in extracellular fluid after opening of the blood-brain barrier by intracarotid infusion of protamine sulfate.
Westergren I; Nyström B; Hamberger A; Nordborg C; Johansson BB
J Neurochem; 1994 Jan; 62(1):159-65. PubMed ID: 8263515
[TBL] [Abstract][Full Text] [Related]
10. Permeability of the blood-brain barrier to melanocortins.
Banks WA; Kastin AJ
Peptides; 1995; 16(6):1157-61. PubMed ID: 8532602
[TBL] [Abstract][Full Text] [Related]
11. Brain implants in man do not break down the blood-brain barrier to dopamine and domperidone.
Clough CG; Hitchcock ER; Hughes RC; Henderson BT; Kenny BG
Brain Res; 1992 Sep; 589(2):E2-4. PubMed ID: 1393589
[TBL] [Abstract][Full Text] [Related]
12. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
[TBL] [Abstract][Full Text] [Related]
13. Altering the blood-brain barrier in the rat by intracarotid infusion of polycations: a comparison between protamine, poly-L-lysine and poly-L-arginine.
Westergren I; Johansson BB
Acta Physiol Scand; 1993 Sep; 149(1):99-104. PubMed ID: 8237428
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical studies of protamine-induced blood-brain barrier opening to endogenous albumin.
Vorbrodt AW; Dobrogowska DH; Ueno M; Lossinsky AS
Acta Neuropathol; 1995; 89(6):491-9. PubMed ID: 7676805
[TBL] [Abstract][Full Text] [Related]
15. Changes in blood-brain barrier permeability to drugs in decompressed rats.
Kaakkola S; Lehtosalo J; Laitinen LA
Undersea Biomed Res; 1982 Sep; 9(3):233-40. PubMed ID: 6890252
[TBL] [Abstract][Full Text] [Related]
16. Dixyrazine, a phenothiazine derivative, can prevent brain oedema induced by intracarotid injection of protamine sulphate.
Westergren I; Johansson BB
Acta Neurochir (Wien); 1991; 113(3-4):171-5. PubMed ID: 1686824
[TBL] [Abstract][Full Text] [Related]
17. Platelet activating factor induces transient blood-brain barrier opening to facilitate edaravone penetration into the brain.
Fang W; Zhang R; Sha L; Lv P; Shang E; Han D; Wei J; Geng X; Yang Q; Li Y
J Neurochem; 2014 Mar; 128(5):662-71. PubMed ID: 24164378
[TBL] [Abstract][Full Text] [Related]
18. Differential action of domperidone to modify emesis and behaviour induced by apomorphine in the ferret.
Lau AH; Ngan MP; Rudd JA; Yew DT
Eur J Pharmacol; 2005 Jun; 516(3):247-52. PubMed ID: 15963978
[TBL] [Abstract][Full Text] [Related]
19. Increase in the hypotensive effect of bromocriptine induced by spinal transection in rats: contribution of spinal dopamine receptors.
Lahlou S; Demenge P
J Cardiovasc Pharmacol; 1992 May; 19(5):723-31. PubMed ID: 1381770
[TBL] [Abstract][Full Text] [Related]
20. Effect of magnesium sulfate administration on blood-brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study.
Esen F; Erdem T; Aktan D; Orhan M; Kaya M; Eraksoy H; Cakar N; Telci L
Crit Care; 2005 Feb; 9(1):R18-23. PubMed ID: 15693962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
